AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads

RecruitingNAAges 18 Years - anyAllMedical University of South Carolina
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

In this randomized behavioral intervention, head and neck cancer (HNC) survivors and their caregivers (N=176 HNC survivor-caregiver dyads) will be randomized to either Survivorship Needs Assessment Planning (SNAP) or Usual Care (UC) groups to examine the effects of SNAP on outcomes. SNAP includes two sessions with a needs assessment and tailored care plan and a supportive mobile app after completion of radiation to promote uptake of recommended medical and supportive care. The study aims to evaluate the effects of SNAP on symptom severity in patients and caregiver burden in caregivers. Secondary outcomes include psychological distress (anxiety and depression), healthcare utilization (receipt of recommended care) and unmet needs and self-efficacy in HNC survivor-caregiver dyads. Participants will complete surveys at baseline, 6 months, and 9 months post randomization with validated PROMs,

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Patient Inclusion Criteria: 1. Age \>18 2. Stage I-IV non-metastatic HNC (i.e., lip/oral cavity, nasopharynx, salivary gland, oropharynx, hypopharynx, paranasal sinus, larynx and cutaneous cancers) 3. Currently receiving radiation treatment (with/without surgery and/or concurrent chemotherapy) with curative intent 4. Able to nominate caregiver, the primary support person, also interested in participating Caregiver Inclusion Criteria: 1. Age \>18 2. Provide care for a loved one with stage I-IV HNC 3. Agrees to participate after being nominated Patient Exclusion Criteria: 1. Patients who do not read/understand English 2. Patients who are cognitively impaired and cannot complete interviews as judged by the referring health care provider 3. Patients concurrently diagnosed with and/or receiving treatment for a second "significant" primary cancer, except the following: * Excised and cured non-melanoma skin cancer * Carcinoma in situ of breast or cervix * Superficial bladder cancer * Stage 1 differentiated thyroid cancer that is resected or observed * pT1a/pT1b prostate cancer comprising \<5% of resected tissue with normal prostate specific antigen (PSA) since resection * cT1a/cT1b prostate cancer treated with brachytherapy Caregiver Exclusion Criteria: 1. Inability to read or understand English 2. Cognitively impaired and cannot complete interviews, as judged by the referring health care provider
๐Ÿ’Š

What it tests

  • Survivorship Needs Assessment Planning (SNAP) tool
๐Ÿ“

Where

1 site
Medical University of South Carolina
Charleston, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy